Stericycle Inc. (SRCL) Given Neutral Rating at Wedbush
Wedbush restated their neutral rating on shares of Stericycle Inc. (NASDAQ:SRCL) in a research report sent to investors on Tuesday. They currently have a $82.00 price target on the stock, down from their previous price target of $85.00.
A number of other research analysts have also recently commented on SRCL. Jefferies Group reiterated a buy rating and issued a $140.00 price target on shares of Stericycle in a research note on Monday, July 18th. Zacks Investment Research upgraded Stericycle from a hold rating to a buy rating and set a $119.00 price target for the company in a research note on Thursday, July 21st. Imperial Capital cut Stericycle from an in-line rating to an underperform rating and dropped their price target for the company from $100.00 to $93.50 in a research note on Friday, July 29th. Wellington Shields cut Stericycle from an accumulate rating to a hold rating in a research note on Friday, July 29th. Finally, Macquarie began coverage on Stericycle in a research note on Thursday, August 25th. They issued a neutral rating and a $96.00 price target for the company. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the company. The company currently has an average rating of Hold and an average price target of $92.75.
Stericycle (NASDAQ:SRCL) traded down 0.43% during midday trading on Tuesday, hitting $74.89. The stock had a trading volume of 414,433 shares. The company’s 50-day moving average price is $76.15 and its 200 day moving average price is $89.56. Stericycle has a 52 week low of $72.20 and a 52 week high of $128.94. The company has a market capitalization of $6.37 billion, a PE ratio of 27.22 and a beta of 0.17.
Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, October 27th. The company reported $1.24 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.17 by $0.07. The firm had revenue of $890.10 million for the quarter, compared to the consensus estimate of $899.87 million. Stericycle had a return on equity of 15.33% and a net margin of 7.52%. The company’s revenue was up 23.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.08 EPS. On average, analysts expect that Stericycle will post $4.74 EPS for the current year.
In other news, EVP John P. Schetz sold 1,398 shares of the business’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total value of $114,426.30. Following the transaction, the executive vice president now owns 1,088 shares in the company, valued at approximately $89,052.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 3.30% of the stock is owned by insiders.
Several institutional investors have recently made changes to their positions in SRCL. Balentine LLC increased its position in shares of Stericycle by 15.0% in the second quarter. Balentine LLC now owns 1,224 shares of the company’s stock worth $127,000 after buying an additional 160 shares during the last quarter. NEXT Financial Group Inc increased its position in shares of Stericycle by 78.0% in the third quarter. NEXT Financial Group Inc now owns 1,620 shares of the company’s stock worth $130,000 after buying an additional 710 shares during the last quarter. Pinkerton Retirement Specialists LLC acquired a new position in shares of Stericycle during the second quarter worth $131,000. Fuller & Thaler Asset Management Inc. acquired a new position in shares of Stericycle during the third quarter worth $136,000. Finally, Parkside Financial Bank & Trust increased its position in shares of Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock worth $149,000 after buying an additional 41 shares during the last quarter. Hedge funds and other institutional investors own 89.05% of the company’s stock.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.